Silswal N, Parelkar NK, Wacker MJ, Brotto M, Andresen J. Phosphatidylinositol 3,5-bisphosphate increases intracellular free Ca 2ϩ in arterial smooth muscle cells and elicits vasocontraction. Am J Physiol Heart Circ Physiol 300: H2016 -H2026, 2011. First published March 18, 2011 doi:10.1152 doi:10. /ajpheart.01011.2010 (51, 59) . In humans, a deleterious allele of FIG4 is a risk factor for amyotrophic and primary lateral sclerosis, and mutations in MTMR genes are associated with myopathies and Charcot-Marie-Tooth diseases (10, 70). Thus, PI(3,5)P 2 appears important in several diseases, although much remains to be learned regarding its function in eukaryotes.
P2] is a newly identified phosphoinositide that modulates intracellular Ca 2ϩ by activating ryanodine receptors (RyRs). Since the contractile state of arterial smooth muscle depends on the concentration of intracellular Ca 2ϩ , we hypothesized that by mobilizing sarcoplasmic reticulum (SR) Ca 2ϩ stores PI(3,5)P2 would increase intracellular Ca 2ϩ in arterial smooth muscle cells and cause vasocontraction. Using immunohistochemistry, we found that PI (3, 5) P2 was present in the mouse aorta and that exogenously applied PI (3, 5) P2 readily entered aortic smooth muscle cells. In isolated aortic smooth muscle cells, exogenous PI(3,5)P2 elevated intracellular Ca 2ϩ , and it also contracted aortic rings. Both the rise in intracellular Ca 2ϩ and the contraction caused by PI (3, 5) P2 were prevented by antagonizing RyRs, while the majority of the PI(3,5)P2 response was intact after blockade of inositol (1,4,5)-trisphosphate receptors. Depletion of SR Ca 2ϩ stores with thapsigargin or caffeine and/or ryanodine blunted the Ca 2ϩ response and greatly attenuated the contraction elicited by PI (3, 5) P2. The removal of extracellular Ca 2ϩ or addition of verapamil to inhibit voltage-dependent Ca 2ϩ channels reduced but did not eliminate the Ca 2ϩ or contractile responses to PI(3,5)P2. We also found that PI(3,5)P2 depolarized aortic smooth muscle cells and that LaCl3 inhibited those aspects of the PI(3,5)P2 response attributable to extracellular Ca 2ϩ . Thus, full and sustained aortic contractions to PI(3,5)P 2 required the release of SR Ca 2ϩ , probably via the activation of RyR, and also extracellular Ca 2ϩ entry via voltage-dependent Ca 2ϩ channels.
aortic smooth muscle cells; calcium; ryanodine receptors; sarcoplasmic reticulum PHOSPHOINOSITIDE (PI) lipids are located on the cytoplasmic face of intracellular membranes, and different isomers have specific subcellular localizations. The hydroxyl groups of the inositol ring of phosphatidylinositol can be variably phosphorylated to form seven distinct PIs. PI (3, 5) -bisphosphate [PI(3,5)P 2 ] is the most recently identified PI bisphosphate isomer (9, 19, 75) , and it is concentrated on intracellular organelles, particularly those of late endosomes, lysosomes, and the sarcoplasmic reticulum (SR) (41, 59) . Synthesis of PI(3,5)P 2 from PI (3)-phosphate [PI(3)P] is catalyzed by a complex of proteins including FAB1, VAC14, and FIG4, which can also remove the 5=-phosphate to regenerate PI(3)P (20) . A family of proteins known as myotubularin and myopathy-related (MTMR) phosphatases removes the 3=-phosphate to generate PI (5)-phosphate [PI(5)P] (31).
Dysfunctions in PI(3,5)P 2 metabolism lead to pathologies (50, 70) . For example, deletion of Vac14 or mutation of Fig4 in mice results in neurodegeneration and premature death (77) . In addition, deletion of Mtmr14 in mice disrupts Ca 2ϩ signaling, causing the muscle weakness and exercise intolerance that is characteristic of centronuclear myopathy (51, 59) . In humans, a deleterious allele of FIG4 is a risk factor for amyotrophic and primary lateral sclerosis, and mutations in MTMR genes are associated with myopathies and Charcot-Marie-Tooth diseases (10, 70) . Thus, PI(3,5)P 2 appears important in several diseases, although much remains to be learned regarding its function in eukaryotes.
Interestingly, PI(3,5)P 2 binds to and activates ryanodine receptors (RyRs), thereby increasing intracellular Ca 2ϩ by emptying SR stores (59, 71) . In arterial smooth muscle, SR Ca 2ϩ contributes to the development and maintenance of vascular tone (52, 73) , but the role of PI(3,5)P 2 in arterial vascular Ca 2ϩ signaling remains undefined. We hypothesized that PI(3,5)P 2 would mobilize SR Ca 2ϩ stores, causing vasocontraction. Therefore, we examined the effects of PI(3,5)P 2 in vitro in isolated mouse aortic smooth muscle cells using ratiometric Ca 2ϩ imaging and in isolated arteries using myography. Our results demonstrated that PI(3,5)P 2 caused contraction of aortic rings by activating RyRs to release SR Ca 2ϩ followed by the opening of voltage-dependent Ca 2ϩ channels (VDCCs). If extracellular Ca 2ϩ entry was prevented, either by blockade of VDCC, by removal of extracellular Ca 2ϩ , or by the inclusion of LaCl 3 , PI(3,5)P 2 still generated transient contractions. Prior depletion of SR Ca 2ϩ stores, however, prevented PI(3,5)P 2 from having any effect. Thus, the activation of RyRs by PI(3,5)P 2 was sufficient to release SR Ca 2ϩ and cause small contractions, whereas VDCCs were required to achieve full increases in intracellular Ca 2ϩ and sustained aortic contractions.
METHODS

Animals and reagents.
Male C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) at 12 wk of age. Mice were killed by CO 2 inhalation. The Animal Care and Use Committee of the University of Missouri-Kansas City approved all protocols. All reagents were purchased from Sigma (St. Louis, MO) unless otherwise noted. PI lipids, including PI(3,5)P 2, PI(3)P, and PI(5)P (Echelon Biosciences, Salt Lake City, UT), were prepared by dissolving them in chloroform, methanol, and water at a ratio of 1:2:0.8 as per the manufacturer's instructions, and just before addition to the bath, they were mixed with histone (Echelon Biosciences) solution at a ratio of 1:0.8. Histone carrier protein, which is required for the intracellular delivery of PIs (46) , stock solution was prepared by dissolving the protein in double-distilled H 2O to a concentration of 1 mM. Solvents never exceeded 0.1% (vol/vol), and vehicle controls included the solvents and histone carrier protein but not the PI lipid.
Immunohistochemistry. The thoracic aorta was removed, cleaned of excess fat and connective tissue, immediately frozen in tissue freezing medium, and sectioned at 8 m using a cryostat. Sections were mounted two to three to a slide and fixed in 4% formaldehyde for 10 min at room temperature. Slides were washed with 0.1% Triton X-100 in PBS (PBS-T) followed by blockade with 5% normal goat serum and 1% BSA (blocking buffer) containing 0.05 g/l of AffiniPure Fab fragment goat-anti mouse IgG (HϩL) for 1 h. Sections were incubated overnight at 4°C with either anti-PI(3,5)P 2 mouse monoclonal IgG 2b antibody in blocking buffer at 1:100 dilution (Echelon Biosciences) or in blocking buffer only. On the second day, sections were allowed to incubate at room temperature for 1 h followed by three washes in PBS-T for 10 min each. Sections were then blocked for 1 h at room temperature with blocking buffer. This was followed by an incubation with a fluorescently tagged DyLight Goat anti-mouse IgG 2b-specific secondary antibody (Jackson ImmunoResearch, West Grove, PA) diluted 1:4,000 in blocking buffer for 1 h at room temperature. Sections were then incubated with 4=,6-diamidino-2-phenylindole (DAPI; 1 g/ml) in blocking buffer for 5 min. Before being coverslipped, sections were washed three times in PBS-T and dehydrated with increasing concentrations of ethanol. Sections were dried and coverslipped using Vectashield HardSet mounting medium (Vector Labs). Slides were imaged by epifluorescence microscopy using an Olympus IX71 (Olympus America, Center Valley, PA) inverted microscope fitted with a Hamamatsu ORCA-R2 chargecoupled device (CCD) camera (Hamamatsu, Bridgewater, NJ) and a Sutter LB-XL light source (Novato, CA). Images were processed with Slidebook software (version 5.0.0.9, Intelligent Imaging Innovations, Denver, CO).
Aorta digestion and smooth muscle cell isolation. Thoracic aortas were excised and cleaned of fat and excess connective tissue in ice-cold HBSS. Sections of aortas 2-3 mm in length were placed in ice-cold (4°C) solution I [127 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 11.8 mM glucose, 10 mM HEPES (pH 7.4), and 2.4 mM CaCl2]. After rings had been washed once in solution I, aortas were cut open longitudinally and placed into a new solution containing albumin (5 mg/ml), papain (3.5 mg/ml), and dithiothreitol (5 mg/ml) in solution I for 25 min at 37°C. Tissue was washed with solution I (2 ϫ 3 min each) and afterward incubated at 37°C in another enzyme solution containing albumin (5 mg/ml), collagenase (2.5 mg/ml), and hyaluronidase (2.5 mg/ml) in solution I for 6 min. Dissociated tissue was washed twice in digestion buffer and then triturated by passing the digest 10 times through the tip of a flame-polished Pasteur pipette. The digest was stored on ice until use during the same day.
Visualization of PI (3, 5) P2 entry into aortic smooth muscle cells. Aortic smooth muscle cells were plated into a glass-bottomed perfusion chamber and placed on the stage of an inverted Olympus IX71 microscope, and cells were bathed in Ca 2ϩ -free HBSS (Invitrogen, Carlsbad, CA). Fluorescently tagged PI(3,5)P2 in the form of BODIPY-TMR PI(3,5)P2 diC6 (Echelon Biosciences) was mixed with the histone carrier protein and added to the cells at 3 M. After being incubated for 5 min, smooth muscle cells were washed three times with Ca 2ϩ -free HBSS and imaged by epifluorescence and phasecontrast microscopy. No fluorescence was observed in aortic smooth muscle cells treated only with vehicle.
Ratiometric Ca 2ϩ imaging. Aortic smooth muscle cells were plated onto glass-bottomed plastic tissue culture dishes (Warner Instruments, Hamden, CT) and incubated with fura 2-AM (2 M, Invitrogen) in HBSS buffer for 30 min and then twice washed with HBSS buffer to remove any unincorporated dye. The dishes were then placed on the stage of an inverted Olympus IX71 microscope and superfused with HBSS or Ca 2ϩ -free HBSS (with 0.4 mM EGTA) as indicated. Images were collected using Hamamatsu ORCA-R2 CCD camera and a Sutter LB-XL light source and processed with Slidebook ratiometric software. Photo toxicity was minimized using a neutral density filter and by keeping exposure times as short as possible. All experiments were performed at room temperature. Data are expressed as a ratio (340/380 nm) of emitted fluorescence at 510 nm in cells excited at 340 and 380 nm. Responses to PI(3,5)P2 (1 or 3 M) alone or in the presence of ryanodine (0.2-50 M), thapsigargin (10 M), verapamil (10 M), caffeine (10 mM), or appropriate vehicle controls were analyzed by directly adding the agonist/antagonists to the bath. Responses of 5-10 cells were averaged to form one observation per treatment per animal (where n is the number of animals).
Isometric tension myography. The thoracic aorta was rapidly excised and placed in ice-cold HBSS, where blood, fat, and excess connective tissues were carefully removed. Segments 3-4 mm in length were mounted on pins in chambers of a DMT 610M wire myograph system (Danish Myo Technology, Aarhus, Denmark) containing Krebs buffer [which contained (in mM) 119 NaCl, 4.7 KCl, 0.24 NaHCO 3, 1.18 KH2PO4, 1.19 MgSO4, 5.5 glucose, and 1.6 CaCl 2] saturated at 37°C with a gas mixture containing 20% O2-5% CO 2-75% N2 (Airgas Mid South, Tulsa, OK). Replacing CaCl2 with 0.4 mM EGTA in standard Krebs buffer produced Ca 2ϩ -free buffer. Arterial rings were progressively stretched to 0.75 g of equivalent force passive tension in 0.1-g steps and allowed to equilibrate for 45 min. To assess the quality of the preparation before the concentrationresponse curve to PI(3,5)P 2 was determined, aortic rings were exposed to isotonic KCl (40 and 80 mM) and also to 10 M PGF 2␣ followed by 1 M ACh. Vessels were rinsed once with fresh Krebs buffer every 15 min and several times after concentration-response curves. The role of extracellular Ca 2ϩ in PI(3,5)P2-mediated contraction was examined by washing aortic segments with Ca 2ϩ -free Krebs buffer for 2 min before the responses to PI(3,5)P2 were determined. Aortic segments were pretreated with verapamil (10 M) for 3 min while with ryanodine (10 or 100 M, Ascent Scientific, Princeton, NJ), thapsigargin (10 M, Alexis, San Diego, CA) alone or together for 20 min before the addition of PI(3,5)P2. Preincubation with caffeine (10 mM) was performed for 5 min to determine its effect on PI(3,5)P2-mediated contraction. Force changes were recorded using an ADInstruments (Colorado Springs, CO) PowerLab 4/30 and associated LabChart Pro software (version 6.1) running on a standard Windows XP computer platform.
Electrophysiology. The membrane potential of freshly dissociated aortic smooth muscle cells was determined by patch-clamp electrophysiology similar to a previous study by our laboratory (47) . Briefly, aortas were enzymatically digested, and smooth muscle cells were isolated as described above. Cells were plated onto the bottom of a laminar perfusion chamber (Bioscience Tools, San Diego, CA) placed on the stage of an Olympus IX71 inverted microscope and bathed in buffer consisting of (in mM) 140 NaCl, 4.2 KCl, 3 Na2CO3, 1.2 KH2PO4, 2 MgCl2, 0.1 CaCl2, 10 glucose, and 10 HEPES (pH 7.4). The pipette buffer consisted of (in mM) 140 KCl, 1 MgCl2, 2.2 CaCl2, 3 EGTA (resulted in ϳ0.42 M free Ca 2ϩ ), and 10 HEPES (pH 7.2). The osmolarity of the bath and pipette solutions was measured using a Wescor VAPRO 5520 vapor pressure osmometer (Logan, UT) and adjusted to ϳ300 mosM if necessary. Micropipettes were made from Warner Instruments 8520 glass capillaries (Hamden, CT) using a Narishige PC-10 gravity puller (East Meadow, NY) and polished to 2-6 M⍀ using a Narishige MF-830 microforge. Electrophysiological recordings were made from 3-6 cells/animal (averaged to form n ϭ 1) using a MultiClamp 700B computer-controlled microelectrode amplifier (Molecular Devices, Sunnyvale, CA) and a DigiData1440A low-noise digitizer (Molecular Devices) run by pCLAMP 10 software (version 10.2.0.14, Molecular Devices).
Statistics. Data are plotted and expressed as means Ϯ SE, with n indicating the number of animals studied for a given treatment. Changes in isometric tension are expressed in grams. In myograph experiments, two-factor ANOVA was used to determine differences in the concentration-response curves. In Ca 2ϩ imaging experiments, Student's t-test was used to determine the significance of differences between two observations, whereas one-factor ANOVA with Tukey's post hoc test was used for multiple comparisons. In isobaric experiments, percent constrictions were expressed as the percent decrease from the baseline diameter of the middle cerebral artery. Data were plotted and statistics computed with Graphpad Prism (version 5.01, San Diego, CA). Significance was accepted at P Յ 0.05.
RESULTS
PI(3,5)P 2 in aortic smooth muscle cells.
In sections of the mouse aorta, we detected red immunofluorescence for PI(3,5)P 2 that overlapped with blue DAPI staining of nuclei in between layers of internal elastic laminae that autofluoresced green (Fig. 1A) . Thus, using epifluorescence microscopy, we found that PI(3,5)P 2 was present at least in the smooth muscle layers of the mouse aorta under basal conditions. Since we planned to determine if PI(3,5)P 2 mobilized internal Ca 2ϩ , we first verified that exogenous PI(3,5)P 2 would enter arterial smooth muscle cells. Similar to a previous report (69), we used epifluorescence microscopy to show that fluorescently tagged PI(3,5)P 2 [BODIPY-TMR PI(3,5)P 2 ] complexed with the histone carrier protein entered isolated aortic smooth muscle cells (Fig. 1B) . Thus, PI(3,5)P 2 was normally present in aortic smooth muscle cells, and we could introduce exogenous PI(3,5)P 2 into isolated aortic smooth muscle cells to study its effects.
Ca 2ϩ and contractile responses to PI(3,5)P 2 . In isolated aortic smooth muscle cells, PI(3,5)P 2 increased intracellular Ca 2ϩ in a concentration-dependent (P Ͻ 0.0001) manner, whereas the vehicle was without any effect (Fig. 2, A and B) . The rise in internal Ca 2ϩ was likely specific to PI(3,5)P 2 because little to no effect was observed using the PI(3,5)P 2 metabolites PI(5)P and PI(3)P. The response to 1 M PI(5)P was indistinguishable from that of vehicle alone, whereas 1 M PI(3)P increased intracellular Ca 2ϩ no more than one-third as effectively as 1 M PI(3,5)P 2 . The 340/380 ratio trace shown in Fig. 2A also demonstrates that 100 mM KCl reliably elicited a maximal Ca 2ϩ response in healthy aortic smooth muscle cells, and only data from cells that responded to KCl were included in the analysis. Since PI(3,5)P 2 increased intracellular Ca 2ϩ in isolated aortic smooth muscle cells, we next determined whether or not PI(3,5)P 2 could also contract the aorta. Using aortic rings held under isometric tension, we found that PI(3,5)P 2 , but not vehicle, caused vasocontraction in a concentration-dependent (P Ͻ 0.0001) manner (Fig. 3) . In addition to this, using isobaric myography, we also found that PI(3,5)P 2 caused concentration-dependent vasoconstriction of isolated middle cerebral arteries (Supplemental Material, Supplemental Fig. S1 ). , we returned to ratiometric Ca 2ϩ imaging of isolated aortic smooth muscle cells. Both RyR1 and RyR2, the latter of which is the predominate subtype found in the vasculature (23, 76) , are directly activated by PI(3,5)P 2 (59, 71) . As previously reported (21, 78), we found that ryanodine up to 10 M released SR Ca 2ϩ , whereas higher concentrations blocked RyRs (Fig. 4A) . Interestingly, both 1 M PI(3,5)P 2 and 1 M ryanodine increased intracellular Ca 2ϩ in a similar manner (Fig. 4B) . Likewise, caffeine, which is a RyR agonist, concentration dependently increased intracellular Ca 2ϩ (Supplemental Fig. S2A) , and an inhibitory concentration of ryanodine completely blocked the caffeine response (Fig.  4D) . Similarly, an inhibitory concentration of ryanodine effectively blocked both the Ca 2ϩ and contractile responses to PI(3,5)P 2 (Fig. 4, C and E) .
To further investigate the effect of SR Ca 2ϩ stores in the PI(3,5)P 2 response, mouse aortic smooth muscle cells were treated with thapsigargin [an inhibitor of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)] or caffeine and/or ryanodine. In ratiometric Ca 2ϩ imaging experiments, preincubation with 10 M thapsigargin, 10 M ryanodine, or 10 mM caffeine essentially eliminated (P Ͻ 0.0001) the PI(3,5)P 2 Ca 2ϩ response (Fig. 5A) . Preincubation of aortic rings with thapsigargin (10 M) likewise prevented PI(3,5)P 2 from causing contractions (Fig. 5B) . Similarly, the application of ryanodine (10 M) and thapsigargin (10 M) together also kept PI(3,5)P 2 from contracting the aorta (Fig. 5B) . Pretreatment with only ryanodine (10 M) to deplete the SR, however, greatly attenuated (P ϭ 0.0136) but did not totally abolish the PI(3,5)P 2 response (Fig. 5B ). For instance, in the presence of 10 M ryanodine, 3 M PI(3,5)P 2 elicited some contraction (Fig. 5B) ; however, it was 60% less than the maximal control response. Furthermore, preincubation with 10 mM caffeine to deplete the SR also prevented PI(3,5)P 2 from contracting the aorta (Supplemental Fig. S2C ).
In addition, the inositol (1,4,5)trisphosphate (IP 3 ) receptor (IP 3 R) blocker xestospongin C (25 M) reduced (P Ͻ 0.0001) the Ca 2ϩ response to 1 M PI(3,5)P 2 by 29%, indicating that IP 3 Rs could also have been activated by PI(3,5)P 2 (Fig. 6) .
Next, we investigated the role of extracellular Ca 2ϩ in the PI(3,5)P 2 response. Interestingly, the removal of extracellular Ca 2ϩ or addition of verapamil (10 M) to block VDCCs similarly reduced, but did not abolish, the response to PI(3,5)P 2 (Fig. 7, A and B) . As shown in Fig. 7B , the Ca 2ϩ response to 1 M PI(3,5)P 2 was reduced by 27% (P Ͻ 0.0001) in Ca 2ϩ -free buffer and by 42% (P ϭ 0.0002) in the presence of verapamil. This could not have simply been due to depletion of -free buffer because, as shown in Supplemental Fig. S2B , the absence of extracellular Ca 2ϩ did not affect the caffeine response. Similarly, verapamil also did not alter (P ϭ 0.7701) the Ca 2ϩ response to 10 mM caffeine, indicating that verapamil had no effect on SR Ca 2ϩ stores (Supplemental Fig. S2B ). Again, similar to the Ca 2ϩ imaging experiments, the removal of extracellular Ca 2ϩ largely, although not completely, inhibited aortic contractions to PI(3,5)P 2 (data not shown). Interestingly, the addition of 10 M verapamil to Ca 2ϩ -containing Krebs buffer allowed only transient contractions to PI(3,5)P 2 (P ϭ 0.0014) that were not sustained at any concentration of PI(3,5)P 2 (Fig. 7, C and D) .
Given that PI(3,5)P 2 appeared to open VDCCs subsequent to RyR activation, we determined whether or not PI(3,5)P 2 also caused membrane depolarization. To do so, we used patchclamp electrophysiology in current clamp mode with freshly isolated aortic smooth muscle cells. We found that the application of 3 M PI(3,5)P 2 elicited depolarizations in 83% of the cells tested that averaged 6.3 Ϯ 3 mV (n ϭ 5). The remainder of the cells either did not respond to PI(3,5)P 2 or showed hyperpolarization, showing that the vehicle could not have caused the depolarization. All cells, however, responded robustly to 60 mM KCl by generating 21 Ϯ 3-mV depolarizations. While examining the effects of inhibiting various pathways that could lead to the depolarization of vascular smooth muscle, we found that LaCl 3 blocked the effects of PI(3,5)P 2 related to entry of extracellular Ca 2ϩ . Using ratiometric Ca 2ϩ imaging, we found that LaCl 3 inhibited (P Ͻ 0.0001) but did not abolish the rise in Ca 2ϩ caused by PI(3,5)P 2 ( Fig. 8 , B and C), whereas it had no effect on the caffeine response (Supplemental Fig. 2B) . Interestingly, the Ca 2ϩ response to PI(3,5)P 2 in the presence of verapamil was indistinguishable (P ϭ 0.7055) from the response with LaCl 3 . In addition, 100 M LaCl 3 impaired (P ϭ 0.0085) but did not eliminate aortic contractions to PI(3,5)P 2 (Fig. 8A) . For example, contraction to 3 M PI(3,5)P 2 was 0.17 g in control rings and 0.04 g in the presence of LaCl 3 (Fig. 8A) . Importantly, we did not observe inhibition of VDCCs by LaCl 3 . This was demonstrated in aortic smooth muscle cells by showing that in the presence of LaCl 3 , 100 mM KCl still elevated intracellular Ca 2ϩ (Fig. 8B ).
DISCUSSION
In this study, we examined the hypothesis that PI(3,5)P 2 would stimulate Ca 2ϩ release from the SR of arterial smooth muscle cells and cause vasocontraction. Below, we present three major novel findings. First, PI(3,5)P 2 is present in arterial smooth muscle under basal conditions. Second, using ratiometric Ca 2ϩ imaging, we demonstrated that PI(3,5)P 2 elevated intracellular Ca 2ϩ in two steps, beginning with the activation of RyRs, which mobilized SR Ca 2ϩ , followed by membrane depolarization and the activation of VDCCs to admit extracellular Ca 2ϩ . Third, PI(3,5)P 2 contracted the mouse aorta in a manner that required RyR-dependent SR Ca 2ϩ release. For contractions to PI(3,5)P 2 to be sustained, extracellular Ca 2ϩ entry via VDCCs was also required. Therefore, we propose that PI(3,5)P 2 stimulates RyRs to release SR Ca 2ϩ , which, by itself, can cause transient contractions, but for contractions to be sustained, additional Ca 2ϩ entry from outside the cell is required. Similar to the aorta, we also found that PI(3,5)P 2 caused vasoconstriction of the mouse middle cerebral artery, which indicates that PI(3,5)P 2 can also constrict resistance arteries. Together, these results expand our understanding of vascular PI lipid signaling by showing that a newly identified PI lipid, PI(3,5)P 2 , can modulate SR Ca 2ϩ release and thus influence the contractile state of arterial smooth muscle. PI(3,5)P 2 has only recently been discovered, and its presence in different tissues is still being understood. We found that PI(3,5)P 2 is present under basal conditions in the smooth muscle cell layers of the mouse aorta. Since there is no known pharmacological way to specifically and selectively increase PI(3,5)P 2 levels, we applied exogenous PI(3,5)P 2 to study its effects. First, however, we verified that PI(3,5)P 2 would enter arterial smooth muscle cells. Using fluorescently tagged PI(3,5)P 2 and epifluorescence microscopy, we found that freshly isolated arterial smooth muscle cells effectively take up PI(3,5)P 2 to the extent that every cell examined was fluorescent. This is identical to a previous study (69) in neutrophils that demonstrated that a variety of PI lipids, including PI(3,5)P 2 , entered cells when complexed to the histone carrier protein. Although it was not possible for us to determine exactly where inside the cell that exogenous PI(3,5)P 2 became concentrated, it appeared to cluster in the interior of the cell and did not highlight the cell membrane. This is consistent with the known localization of PI(3,5)P 2 in the membranes of intracellular organelles, including the SR (59) .
The Ca 2ϩ and contractile responses to exogenous PI(3,5)P 2 were likely specific to PI(3,5)P 2 because exogenous application of the PI(3,5)P 2 metabolites PI(3)P or PI(5)P was largely without effect. The Ca 2ϩ response to PI(3)P, although minor, was predictable because PI(3)P and PI(3,5)P 2 can be interconverted. These data perhaps indicate that, within the time frame of our experiments, metabolism of PIs did not significantly contribute to the observed responses. Thus, the effects of exogenous PI(3,5)P 2 were most likely due to PI(3,5)P 2 itself and not a metabolite. The aortic contractions caused by PI(3,5)P 2 appeared dependent on both intracellular and extracellular Ca 2ϩ . One of the mechanisms by which Ca 2ϩ is released into the cytoplasm to elicit contraction occurs through RyR channels located in the SR membrane (35) . There are three molecularly distinct subtypes of RyR channels (RyR1, RyR2, and RyR3), and all three are present in the mouse aorta (24) . Ryanodine, at Յ10 M, activates RyR channels and empties SR Ca 2ϩ pools, whereas Ͼ10 M ryanodine blocks RyR channels (40, 78) , which we confirmed in our experiments. Interestingly, the Ca 2ϩ release caused by 1 M ryanodine was very similar to as that of 1 M PI(3,5)P 2 , suggesting that ryanodine and PI(3,5)P 2 release SR Ca 2ϩ in the same manner. We found that inhibitory concentrations of ryanodine prevented PI(3,5)P 2 from eliciting a Ca 2ϩ response in isolated aortic smooth muscle cells and also blocked contraction of the mouse aorta. Depletion of SR stores with thapsigargin, ryanodine, and/or caffeine greatly reduced the Ca 2ϩ response to PI(3,5)P 2 and abolished PI(3,5)P 2 -induced contractions. Therefore, we hypothesize that in aortic smooth muscle PI(3,5)P 2 releases SR Ca 2ϩ by activating RyRs. In support of this hypothesis, Shen et al. (59) found that PI(3,5)P 2 bound to and directly activated RyR1. Importantly, we (71) recently found that PI(3,5)P 2 also binds to and activates RyR2. Because ryanodine completely blocked both the Ca 2ϩ and contractile responses to PI(3,5)P 2 , it was unlikely that the other SR Ca 2ϩ -release mechanism, IP 3 Rs, were involved in the PI(3,5)P 2 response. Regardless, we investigated the possibility that PI(3,5)P 2 could also activate IP 3 Rs by blocking them with xestospongin C. In the presence of xestospongin C, the majority of the Ca 2ϩ response to PI(3,5)P 2 was intact. Although selective for IP 3 R, xestospongin C also inhibits SERCA; thus, it may be that SR stores were partially depleted by the inhibitor (13) . If so, xestospongin C would be expected to decrease the PI(3,5)P 2 response. In this way, xestospongin C would be acting similarly to thapsigargin, which itself reduced, but did not eliminate, the rise in intracel- lular Ca 2ϩ caused by PI(3,5)P 2 . Considering that ryanodine alone, which is highly specific for RyRs without affinity for IP 3 Rs, abolished the responses to PI(3,5)P 2 , our data overall suggest that in aortic smooth muscle the ryanodine-sensitive SR Ca 2ϩ pool may be mobilized by PI(3,5)P 2 to increase intracellular Ca 2ϩ . Nevertheless, the possibility that IP 3 Rs may also contribute to the PI(3,5)P 2 response deserves future attention.
In the vasculature, L-type VDCCs are the major pathway for extracellular Ca 2ϩ entry and are important regulators of vascular tone (38 caused by PI(3,5)P 2 . This was not, however, simply an effect of removing extracellular Ca 2ϩ or of verapamil on SR stores because neither of these conditions altered the rise in intracellular Ca 2ϩ caused by caffeine. It seems then that the PI(3,5)P 2 -mediated increase in intracellular Ca 2ϩ observed in the presence of verapamil or Ca 2ϩ -free buffer was due to Ca 2ϩ release from the SR. This conclusion is supported by the observation that the increase in intracellular Ca 2ϩ was substantially attenuated when the SR Ca 2ϩ pool was depleted by pretreatment with thapsigargin or caffeine. An earlier study (34) , which found that PI(3,5)P 2 did not directly stimulate L-type VDCCs in vascular myocytes, also reinforces this conclusion.
Using patch-clamp electrophysiology, we found that PI(3,5)P 2 elicited membrane depolarization. Although not large, a 6-mV depolarization is substantial enough to increase the open probability of VDCCs, elevate intracellular Ca 2ϩ , and cause vasoconstriction (28, 29, 43) . In cerebral arteries, for example, a 9-mV depolarization opens VDCCs, admits extracellular Ca 2ϩ , and causes 25% constriction (28) , which is on par with our results. In vascular smooth muscle, depolarization may occur by one of three main mechanisms, including inhibition of K ϩ channels, activation of Cl Ϫ channels, or activation of cationic transient receptor potential (TRP) channels.
Since PI(3,5)P 2 did not cause the entry of extracellular Ca 2ϩ (via VDCCs) without first acting on the SR, we conclude that PI(3,5)P 2 did not appreciably act on any ion channel within the plasma membrane. In addition, since PI(3,5)P 2 first acts by raising intracellular Ca 2ϩ , we considered it unlikely that K ϩ channel inhibition could have been responsible for the depolarization because the open probability of many K ϩ channels is actually enhanced by increases in intracellular Ca 2ϩ . The fact that PI(3,5)P 2 raised intracellular Ca 2ϩ levels makes the Ca 2ϩ -activated Cl Ϫ channel an attractive candidate for the depolarization because in vascular smooth muscle the equilibrium potential for Cl Ϫ is depolarized compared with the resting membrane potential (1). Although there are no specific inhibitors of Ca 2ϩ -activated Cl Ϫ channels, we used perhaps one of the best, or at least one of the most commonly used inhibitors, DIDS, to determine if PI(3,5)P 2 activated a Cl Ϫ channel. Consistent with numerous reports (16 -18, 27, 33, 74) detailing nonspecific effects of Cl Ϫ channel inhibitors, we found that DIDS alone increased intracellular Ca 2ϩ in isolated aortic smooth muscle cells (data not shown), which is the opposite of what we predicted. Thus, we did not find DIDS to be a useful tool and consider that a complete investigation of Ca 2ϩ -activated Cl Ϫ channels as a component of the PI(3,5)P 2 response is a subject best left for future investigation.
In contrast, the pan-TRP channel inhibitor LaCl 3 acted very much like verapamil or zero extracellular Ca 2ϩ . That is, LaCl 3 reduced, but did not eliminate, the rise in intracellular Ca 2ϩ or the contractions caused by PI(3,5)P 2 . Because LaCl 3 is not specific for TRP channels, it is important to point out that we did not observe nonspecific inhibition of VDCCs by LaCl 3 . In vascular smooth muscle, TRP channels can be activated by depletion of SR Ca 2ϩ stores and may interact directly with the SR via RyRs and IP 3 Rs (3-5, 14, 22, 25, 44, 48, 54 -57, 60, 61, 68) . Thus, we believe it is possible, but not assured, that the activation of RyRs by PI(3,5)P 2 causes cationic TRP channels to open, thereby depolarizing the membrane and activating VDCCs. At this time, however, we are not prepared to definitively claim that this mechanism accounts for the activation of VDCCs by PI(3,5)P 2 . This is because the available pharmacology is suboptimal and also because of the great variety of TRP channels that could possibly be involved. In addition, we have not been able to rule out a role for Ca 2ϩ -activated Cl Ϫ channels, the molecular identity of which is still uncertain. Therefore, we believe that full elucidation of the mechanism by which PI(3,5)P 2 causes depolarization is beyond the scope of the present study.
Abnormalities in Ca 2ϩ signaling have been described in cardiovascular diseases, and pharmacological blockers of VDCCs are used in the treatment of hypertension and angina (30, 37, 42) . As our experiments demonstrate, PI(3,5)P 2 modulates Ca 2ϩ signaling in vascular smooth muscle, and, therefore, it may regulate cardiovascular function. In this way, PI(3,5)P 2 joins rank with the better-known PI bisphosphate lipid PI (4,5)-bisphosphate [PI(4,5)P 2 ], which is often referred to simply as PIP 2 . Perhaps the best-known effect of PI(4,5)P 2 is its degradation by receptor-activated phospholipase C to generate IP 3 and diacylglycerol (DAG). While the signal transduction cascades initiated by the cleavage of PI(4,5)P 2 into IP 3 and DAG are well appreciated, the direct actions of PI(4,5)P 2 are less well known. As a component of the plasma membrane, PI(4,5)P 2 has access to membrane-bound proteins including ion channels, and it has both direct and indirect actions on a variety of ion channels. For example, KCNQ channels require PI(4,5)P 2 , and its depletion inhibits the channel (62, 64, 66, 67) . In addition, in vascular smooth muscle, TRPC1 is activated by PI(4,5)P 2 , whereas TRPC6 is inhibited by it (2, 32, 53) . Opening of VDCCs may also be modulated by PI(4,5)P 2 via a complicated interaction with arachidonic acid (49) . Typically, however, PI(4,5)P 2 acts to increase ion channel activity, although that is far from the limit to PI(4,5)P 2 's actions, which have been well reviewed by Hille in 2005 and 2008 (63, 65) .
Compared with PI(4,5)P 2 , much less is known about the actions of PI(3,5)P 2 . The synthesis of PI(3,5)P 2 is tightly regulated, and changes in its levels may be protective or deleterious. In yeast, there is a dramatic and transient rise in PI(3,5)P 2 levels of up to 20-fold in response to hyperosmotic shock (9) . In the mammalian cell line of differentiated 3T3-L1 adipocytes, PI(3,5)P 2 levels also increased with hyperosmotic stress (58) . Similarly, IL-2 and ultraviolet exposure also stimulated PI(3,5)P 2 formation in T lymphocytes (26) . Insulin also appears to stimulate the production of PI(3,5)P 2 , which causes glucose transporter 4 to translocate to the plasma membrane (6) . Thus, it appears that, in general, PI(3,5)P 2 levels are increased as a protective mechanism to deal with cellular stress (19) .
Mutations in genes that affect enzymes responsible for PI(3,5)P 2 metabolism are also linked to human diseases (12, 15, 39, 45, 72) . For example, in humans, mutations of PI 3-kinase results in Francois-Neetens-Mouchetee fleck corneal dystrophy (36) , mutations in MTMR2 cause Charcot-MarieTooth type 4B (7, 8) , and mutations of FIG4/SAC3 cause Charcot-Marie-Tooth type 4J (11) . PI(3,5)P 2 levels are also elevated in skeletal muscles of MIP/MTMR14 phosphatase knockout mice, resulting in basal Ca 2ϩ leakage from the SR by the direct activation of RyR1 (59) . Therefore, control of PI(3,5)P 2 appears critical for the proper regulation of intracellular Ca 2ϩ levels in skeletal muscle. While it is too soon to speculate how increases in PI(3,5)P 2 might be protective in the vasculature, or how decreased levels may contribute to disease, it may be that PI(3,5)P 2 levels are increased in cardiovascular disease states. Our experiments are, therefore, a first step toward understanding the physiological role for PI(3,5)P 2 in the cardiovascular system.
In summary, we demonstrated, for the first time, that PI(3,5)P 2 elevates intracellular Ca 2ϩ in aortic smooth muscle cells and induces vasocontraction of aortic rings. The increase in intracellular Ca 2ϩ and contraction was caused first by SR Ca 2ϩ release via the activation of RyRs followed by membrane depolarization that opened VDCCs, thereby admitting extracellular Ca 2ϩ . While it is possible to speculate how the activation of RyRs by PI(3,5)P 2 could lead to membrane depolarization, there are challenges, such as limited pharmacological and genetic tools for the study of TRP channels and Cl Ϫ channels, in particular, that make full exploration of this aspect of the mechanism outside the extent of the present investigation. Future studies will address this as well as the consequences of altered PI(3,5)P 2 signaling on arterial smooth muscle and its implications in cardiovascular health and disease.
